Majolino I, Buscemi F, Scimé R, Indovina A, Santoro A, Vasta S, Pampinella M, Catania P, Fiandaca T, Caronia F
Department of Hematology, Ospedale Cervello, Palermo, Italy.
Haematologica. 1995 May-Jun;80(3):219-26.
Utilization of peripheral blood stem cells (PBSC) in allogeneic transplantation requires a method for their mobilization and collection that is not inconvenient for the donor.
We administered rhG-CSF (filgrastim) 16 micrograms/kg subcutaneously for 4 days in five normal subjects (age 18-31, M = 3, F = 2), previously selected as HLA-identical donors of siblings with leukemia. All the donors gave written informed consent. On days 4 and 5 (in one donor on day 6 too), 10:l leukapheretic collection was performed with a CS-3000 (Baxter) or an AS-104 (Fresenius) cell separator through the antecubital vein.
The WBC count reached a median peak of 57.0 x 10(9)/L on day 5. The peripheral blood CFU-GM peaked to a median level of 8908/mL on day 5 with a median increase over baseline values of 39.1 times. The CD34+ cells peaked to (median) 147.0 x 10(6)/L on day 4 with a median increase of 65.3 times. A lesser enrichment was recorded for BFU-E (median increase 12.7 times) and CFU-GEMM (median increase 15.2 times). Even CD3+ and CD56+CD3- cells increased (median 1.7 and 1.5 times, respectively). A median of 771 x 10(8) MNC (range 672-1378), 116.4 x 10(6) CFU-GM (range 47.7-145.1) and 754 x 10(6) CD34+ cells (range 477-2599) were apheretically collected. Concerning side effects, mild to moderate back pain and general minor discomfort were reported by all donors. The platelet level regularly but transiently decreased after completion of the apheretic procedures with a median nadir of 69 x 10(9)/L (range 43-126) on (median) day 7, but in no case did thrombocytopenia cause bleeding. The thrombocytopenia was more pronounced with the CS-3000 than the AS-104 apparatus.
rhG-CSF 16 micrograms/kg x 4 days is an efficient schedule for PBSC mobilization in healthy donors, but lower doses and even a single apheresis procedure might prove similarly adequate.
在异基因移植中使用外周血干细胞(PBSC)需要一种对供体来说不太不便的动员和采集方法。
我们对五名正常受试者(年龄18 - 31岁,男性3名,女性2名)皮下注射重组人粒细胞集落刺激因子(rhG - CSF,非格司亭),剂量为16微克/千克,共4天,这些受试者之前被选为白血病同胞的HLA相同供体。所有供体均签署了书面知情同意书。在第4天和第5天(一名供体在第6天也进行了),使用CS - 3000(百特公司)或AS - 104(费森尤斯公司)细胞分离器通过肘前静脉进行10:1的白细胞单采采集。
白细胞计数在第5天达到中位数峰值57.0×10⁹/L。外周血粒系集落形成单位(CFU - GM)在第5天达到中位数峰值8908/mL,较基线值中位数增加39.1倍。CD34⁺细胞在第4天达到(中位数)147.0×10⁶/L,中位数增加65.3倍。爆式红系集落形成单位(BFU - E)(中位数增加12.7倍)和粒 - 红 - 巨噬 - 巨核系集落形成单位(CFU - GEMM)(中位数增加15.2倍)的富集程度较低。甚至CD3⁺和CD56⁺CD3⁻细胞也增加了(中位数分别为1.7倍和1.5倍)。通过单采法中位数采集到771×10⁸单个核细胞(范围672 - 1378)、116.4×10⁶CFU - GM(范围47.7 - 145.1)和754×10⁶CD34⁺细胞(范围477 - 2599)。关于副作用,所有供体均报告有轻度至中度背痛和一般轻微不适。单采程序完成后血小板水平有规律但短暂下降,在(中位数)第7天中位数最低点为69×10⁹/L(范围43 - 126),但在任何情况下血小板减少均未导致出血。使用CS - 3000时血小板减少比使用AS - 104设备时更明显。
rhG - CSF 16微克/千克×4天是健康供体中有效动员PBSC的方案,但较低剂量甚至单次单采程序可能同样适用。